Hong Kong SAR

Impro Precision Industries has raised HK$999.9m ($127.94m) from its float on the Hong Kong Stock Exchange, pricing the offering near the middle of initial guidance.

Veteran loans banker Phil Lipton is leaving HSBC after 15 years.

Hong Kong financial institution AMTD International is seeking to raise up to $200m through a US float.

In this round-up, US president Donald Trump and Chinese president Xi Jinping agreed to meet this month, the first active exchange-traded fund listed on the Hong Kong Stock Exchange (HKEX) and the volume of outstanding local government bonds rose again in May.

Chinese local government financing vehicles (LGFVs) and property developers took advantage of positive sentiment after dovish comments from the Federal Reserve to flood the offshore market with bonds.

E-commerce giant Alibaba Group Holding’s planned IPO of up to $20bn in Hong Kong is set to trigger a wave of other technology listings in the city, if successful. The timing couldn’t be better, as the US sets its sights on Chinese companies listed in New York. Gina Lee and Jonathan Breen report.

I would like to think that most of the bankers I know pore over the minutiae of deal documents, but there are always exceptions to the rule.

China’s Ministry of Finance has sold its first offshore renminbi bond of 2019, raising Rmb5bn ($729m) on Thursday.

Hong Kong Exchanges and Clearing is adding to its structured products offering with the launch of inline warrants.

Hong Kong’s securities watchdog has fined Credit Suisse HK$2.8m ($357,770) for failing to meet disclosure requirements when publishing research reports about Hong Kong-listed securities.

Chinese property manager JY Grandmark Holdings is looking to raise up to $200m from an IPO in Hong Kong, according to a source close to the deal.

Biotechnology company WuXi Biologics Holdings has completed a HK$3.81bn ($487m) sale of a part of its stake in subsidiary WuXi Biologics (Cayman), its second sell-down in the stock in less than three months.